NQO1 and metabolic syndrome: Pharmacological stimulation of NADH oxidation via NQO1-mediated catalysis has been associated with amelioration of both obesity20 and hypertension21 in mice, suggesting that NQO1 upregulation may be an effective therapeutic strategy for treating metabolic syndrome.